Karipazim: Enzyme remedy from Georgia to combat purulent-necrotic processes
Karipazim is a pharmaceutical drug developed and produced in Georgia, which is used to treat purulent-necrotic processes. It belongs to a group of enzyme agents that are widely used in medical practice to stimulate wound healing, remove necrotic tissue and fight infection.
The country of origin of Karipazim is Georgia, known for its traditions in the field of pharmaceuticals. The drug is produced by the Institute of Pharmacochemistry named after I.G. Kutateladze, which is a leading scientific institution in the field of pharmacology and medicinal chemistry in Georgia.
Karipazim has an international name, by which it is known outside Georgia. The drug is presented in powder dosage form, which undergoes a lyophilization process to ensure a long shelf life and ease of use. The concentration of active enzyme in the powder is 350 PE (peptite units).
Purulent-necrotic processes are a serious problem that requires complex treatment. Karipazim has properties that contribute to the effective treatment of such processes. It contains enzymes that are able to destroy necrotic tissue and wash wounds, which helps cleanse and heal the affected areas. In addition, the drug has antimicrobial properties, which helps fight infection and prevent its spread.
The use of Karipazim should be carried out under the supervision of a physician, since the dosage and method of administration depend on the nature and extent of the purulent-necrotic process. The drug can be used either alone or in combination with other medications and treatment methods.
Karipazim is one of the successful developments of the Georgian pharmaceutical industry. Its effectiveness and safety have been confirmed by clinical studies, and it is widely used in medical practice for the treatment of purulent-necrotic processes. Thanks to its properties, Karipazim promotes rapid tissue restoration and improves the quality of life of patients suffering from such conditions.
In conclusion, Karipazim is a pharmaceutical drug developed in Georgia to combat purulent-necrotic processes. It is a lyophilized powder of 350 PE and contains enzymes that help remove necrotic tissue, wash wounds and fight infection. Karipazim is produced by the Institute of Pharmacochemistry named after. I.G. Kutateladze Academy of Sciences of Georgia and is widely used in medical practice, both independently and in combination with other treatment methods. This drug is an example of the successful development of the Georgian pharmaceutical industry and helps patients quickly recover from purulent-necrotic processes, improving their quality of life.